Intarcia Therapeutics Patents – Key Insights and Stats

Intarcia Therapeutics has a total of 662 patents globally, out of which 367 have been granted. Of these 662 patents, more than 51% patents are active. The United States of America is where Intarcia Therapeutics has filed the maximum number of patents, followed by Australia and Japan. Parallelly, United States of America seems to be the main focused R&D center and also is the origin country of Intarcia Therapeutics.

Intarcia Therapeutics was founded in 1995. Intarcia Therapeutics operates as a biopharmaceutical company. The Company develops and commercializes therapies to enhance treatment outcomes.

Read about some of the most popular patents of Intarcia Therapeutics which have been covered by us in this article and also you can find Intarcia Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Intarcia Therapeutics patent portfolio.

How many patents does the CEO of Intarcia Therapeutics have?

The CEO Kurt C. Graves has 20 patents.

How many patents does Intarcia Therapeutics have?

Intarcia Therapeutics has a total of 662 patents globally. These patents belong to 85 unique patent families. Out of 662 patents, 344 patents are active.

How Many Patents did Intarcia Therapeutics File Every Year?

Intarcia Therapeutics Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantIntarcia Applications FiledIntarcia Patents Granted
20111618
20122128
2013627
2014117
20151010
20167512
20172947
20183126
20192212
2020916
20211411
202226

How many Intarcia Therapeutics patents are Alive/Dead?

Worldwide Patents

Intarcia Therapeutics Patents Portfolio

How Many Patents did Intarcia Therapeutics File in Different Countries?

Intarcia Therapeutics Worldwide Patents

Countries in which Intarcia Therapeutics Filed Patents

CountryPatents
United States Of America137
Australia57
Japan52
Hong Kong (S.A.R.)47
Europe43
China42
New Zealand36
Israel35
Canada31
Korea (South)27
Germany21
India16
Denmark13
Mexico13
Spain10
Singapore9
Russia9
Austria8
Portugal5
Poland5
Cyprus5
Taiwan4
Argentina4
Slovenia3
Brazil3
Croatia2
United Kingdom2
Macao2
Albania1
Hungary1
Czech Republic1
Lithuania1

Where are Research Centers of Intarcia Therapeutics Patents Located?

Research Centers of Intarcia Therapeutics Patents

10 Best Intarcia Therapeutics Patents

US6375978B1 is the most popular patent in the Intarcia Therapeutics portfolio. It has received 458 citations so far from companies like Atyr Pharma Inc, Abbvie Inc and Pfizer Inc.

Below is the list of 10 most cited patents of Intarcia Therapeutics:

Publication NumberCitation Count
US6375978B1458
US6395292B2337
US6939556B2205
US6923800B2199
US6635268B2199
US7014636B2159
US6508808B1158
US6524305B1157
US6544252B1148
US7258869B1132

What Percentage of Intarcia Therapeutics US Patent Applications were Granted?

Intarcia Therapeutics (Excluding its subsidiaries) has filed 177 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 97 have been granted leading to a grant rate of 69.7%.

Below are the key stats of Intarcia Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Intarcia Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Cooley Llp7187.69%
Intarcia Therapeutics Inc374.55%
Lathrop Gpm Llp1886.67%
Joseph F Shirtz50%
Robert G Mukai40%
Dechert Llp30.00%
Pauline Ann Clarke30%
Bakerhostetler20%
Dewipat Incorporated20%
Alza Corporation10%

EXCLUSIVE INSIGHTS COMING SOON!

What are Intarcia Therapeutics key innovation segments?

What Technologies are Covered by Intarcia Therapeutics?

The chart below distributes patents filed by Intarcia Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Intarcia Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Intarcia Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Intarcia Therapeutics?

Updated on June 22, 2022

Was this article helpful?

Leave a Comment